In Brief: Celgene thalidomide
Executive Summary
Celgene thalidomide: Phase II/III pivotal trial preliminary results with thalidomide in HIV-related weight loss are statistically significant, company reports Jan. 29. Celgene hopes to file an NDA for thalidomide in AIDS wasting by the end of April...